KDM6A and colorectal carcinoma: Since reduced UTX expression in intestinal tissue significantly increased the H3K27me3 levels, which are enriched in CRC with more advanced disease stages, we speculated that targeting H3K27me3 may be an effective way to treat UTX loss-related CRC.